APOA1 and chronic myelogenous leukemia, BCR-ABL1 positive: Treatment of apoA-I with GIGB-258 at the molar ratio 1:0 and 1:0.1 displayed a non-significant (p > 0.05) effect against CML-induced ROS generation.